News & Blog

Potential Glioblastoma Treatments Entering The Pivotal Phase of Evaluation

Jump Ahead to List of Trials Glioblastoma (GBM) is the most common and aggressive malignant brain tumor and, regrettably, very limited treatment options exist for these patients. The current standard-of-care for newly diagnosed patients is surgery, followed by radiation and chemotherapy (with temozolomide), and, in some cases, use of the tumor-treating-field device, Optune. If and […]

From the CEO’s Desk: Know Your Options – A New Resource for Brain Tumor Patients

The new NBTS Clinical Trial Finder will make it easier for brain tumor patients to find up-to-date information on clinical trials, enabling patients to better engage with medical research and make more informed decisions about their own treatment options – including clinical trials – in the emerging era of precision medicine. Dear Brain Tumor Community: […]

Brain Tumor Research Highlights: February 2017

See January 2017’s Brain Tumor Research Highlights here. Over the years, NBTS has given more than $35 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship […]

Share